Nelk Boys to Partner With Safety Shot to Bring the Recovery & Wellness Drink to Fans and Followers

Safety Shot, Inc.
3 min read
0
In this article:
Safety Shot, Inc.Safety Shot, Inc.
Safety Shot, Inc.

  • The Nelk Boys, a widely followed YouTube and social media entertainment groups, join Safety Shot as brand ambassadors

  • With over 10 million subscribers across their channels on YouTube, more than 1.6 billion views, and 4.3 million followers on Instagram, the Nelk Boys are some of the most recognizable internet personalities in North America

  • Safety Shot — Extend the night, enhance the morning

JUPITER, FL, April 09, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced that the Nelk Boys have joined forces with Safety Shot as brand ambassadors.

The Nelk Boys are an entertainment and retail company with YouTube channels under brands including NELK and Full Send that feature prank videos and high profile guests like Elon Musk, Donald Trump, and Mike Tyson. The Nelk Boys have popularized and trademarked the term “Full Send” which they brand as FULL SEND to mean “any activity you do, give it your absolute best”.

“The Nelk Boys, their FULL SEND podcast, and their branded products are a cultural and entertainment sensation. We’re so pleased they’re on board with Safety Shot and look forward to lots of joint product promotions and activities,” stated Safety Shot’s CRO Josh Wagner.

Safety Shot is a patented wellness beverage that reduces blood alcohol content in as little as 30 minutes. Fast acting Safety Shot reduces blood alcohol content through several factors that help process alcohol more efficiently, while also helping the body maintain hydration and improve the overall feeling of wellbeing through nootropics and vitamins.

About Safety Shot, Inc.

Safety Shot, Inc. has developed a first-of-its-kind beverage that makes you feel better faster from the effects of alcohol by reducing blood alcohol content and increasing mental clarity. Safety Shot leverages significantly proven ingredients to enhance metabolic pathways responsible for breaking down blood alcohol levels. The formulation includes a tailored selection of all-natural vitamins, minerals, and nootropics, promoting faster alcohol breakdown and aiding in recovery and rehydration. Safety Shot has been available for retail purchase since the first week of December 2023 at www.DrinkSafetyShot.com and www.Amazon.com. In addition, the Company plans to introduce business-to-business sales to distributors, retailers, restaurants, and bars in 2024.

Forward Looking Statements

This communication contains forward-looking statements regarding Safety Shot, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Safety Shot’s control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Safety Shot and, including those described from time to time under the caption “Risk Factors” and elsewhere in Safety Shot’s Securities and Exchange Commission (SEC) filings and reports, including Safety Shot’s Annual Report on Form 10-K for the year ended December 31, 2023 and future filings and reports by Safety Shot. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Safety Shot on its website or otherwise. Safety Shot undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

Media Contact:
Medon Michaelides
Investor Relations
Phone: 561-244-7100
Email: investors@drinksafetyshot.com

###


Advertisement

Recommended Stories

  • CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs

    The U.S. healthcare giant cut its per-share adjusted earnings forecast for 2024 to at least $7.00 from at least $8.30, adding it anticipates the surge in medical procedures at its unit that houses health insurer Aetna to persist. U.S. health insurers have had to contend with rising medical costs over the past few quarters following higher demand for procedures, especially among older adults, that were delayed during the pandemic. CVS said in February it was seeing a rise in hip and knee surgeries, medical services related to the eyes, dental work, as well as vaccinations including the RSV shot during the last three months of 2023.

  • Kamala Harris Gives Power Suit Playful Details With Polka-dot Pussy-bow Blouse for ‘The Drew Barrymore Show’

    The vice president of the United States spoke with the talk show host about reproductive rights and more.

  • Pot stocks soar on report DEA will ease restrictions on cannabis

    The move from the DEA would reclassify cannabis as a Schedule III drug alongside other drugs like ketamine and some anabolic steroids.

  • Tilray, Other Marijuana Stocks Are Rising. The DEA May Reclassify Marijuana.

    The DEA will move to reclassify marijuana to recognize the medical uses of cannabis, however, it would not legalize marijuana outright for recreational use, an AP report said.

  • Walmart Is Shutting Its Health Centers. What It Means for Amazon’s One Medical.

    Walmart is bowing out of the healthcare business just five years after entering the market, as it moves to close all 51 of its health centers and telehealth business. The decision comes a little over a year since rival Amazon.com  completed the purchase of its own healthcare provider—and is leaning into the industry even as Walmart is cutting back.

  • Former students of the for-profit Art Institutes are approved for $6 billion in loan cancellation

    The Biden administration on Wednesday said it will cancel $6 billion in student loans for people who attended the Art Institutes, a system of for-profit colleges that closed the last of its campuses in 2023 amid accusations of fraud. Saying the chain lured students with “pervasive” lies, the Education Department is invoking its power to cancel student loans for borrowers who were misled by their colleges. “This institution falsified data, knowingly misled students, and cheated borrowers into taking on mountains of debt without leading to promising career prospects at the end of their studies,” President Joe Biden said in a statement.

  • How Adidas Beat Expectations for Q1

    Adidas sales grew 8 percent over the first quarter and the company returned to profit. Adidas boss Bjorn Gulden explained why the German sportswear giant had performed better than expected.

  • McKinsey tried to boost the morale of senior staff by blasting Eminem and Bob Marley at an internal event, report says

    The consulting giant has had a difficult 18 months, global managing partner Bob Sternfels reported admitted as he tried to rally senior partners.

  • Trials to watch: Four ALS drugs to keep an eye on

    There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.

  • New era for pot regulation leaves old problem: Many cannabis companies can't find a bank

    The Biden administration's move to reclassify marijuana as a less dangerous but still controlled drug was hailed as a monumental step in reshaping national policy. “As far as financial institutions, I don’t necessarily think it’s going to have a demonstrable effect” on how they deal with cannabis operators, said Morgan Fox, political director for the National Organization for the Reform of Marijuana Laws, or NORML. “Any potential decision from the administration to reclassify cannabis has no bearing on the legal issues around banking cannabis," said Blair Bernstein, a spokesperson for the American Bankers Association.